中国当代医药
中國噹代醫藥
중국당대의약
PERSON
2014年
30期
12-14,23
,共4页
聚桂醇%用药时间%婴幼儿%血管瘤
聚桂醇%用藥時間%嬰幼兒%血管瘤
취계순%용약시간%영유인%혈관류
Lauromacrogol%Medication time%Infantile%Hemangioma
目的:比较1%聚桂醇不同时间用药治疗婴幼儿血管瘤的临床效果。方法按照随机数字表法将80例血管瘤患儿分为A、B、C、D组,A组未经任何药物治疗,B组采用1%聚桂醇术前30 min瘤体注射,C组采用1%聚桂醇术前48 h瘤体注射,D组采用1%聚桂醇术前2周瘤体注射,比较4组患儿VEGF评分、MVD评分及临床疗效。结果 A组患儿CD34阳性反应呈棕褐色颗粒,强阳性表达。 A、B组患儿VEGF评分及MVD评分比较,差异无统计学意义(P跃0.05);C组患儿VEGF评分及MVD评分显著低于A、B组,差异有统计学意义(P<0.05);D组患儿VEGF评分及MVD评分显著低于A、B、C组,差异有统计学意义(P<0.05)。A、B组患儿总有效率比较差异无统计学意义(P跃0.05);C组患儿总有效率高于A组,差异有统计学意义(P<0.05);D组患儿总有效率高于A、B组,差异有统计学意义(P<0.05)。结论1%聚桂醇术前2周瘤体注射应用于婴幼儿血管瘤,操作简单方便,治疗有效率较高,可有效促进瘤体消退,改善患儿的预后情况。
目的:比較1%聚桂醇不同時間用藥治療嬰幼兒血管瘤的臨床效果。方法按照隨機數字錶法將80例血管瘤患兒分為A、B、C、D組,A組未經任何藥物治療,B組採用1%聚桂醇術前30 min瘤體註射,C組採用1%聚桂醇術前48 h瘤體註射,D組採用1%聚桂醇術前2週瘤體註射,比較4組患兒VEGF評分、MVD評分及臨床療效。結果 A組患兒CD34暘性反應呈棕褐色顆粒,彊暘性錶達。 A、B組患兒VEGF評分及MVD評分比較,差異無統計學意義(P躍0.05);C組患兒VEGF評分及MVD評分顯著低于A、B組,差異有統計學意義(P<0.05);D組患兒VEGF評分及MVD評分顯著低于A、B、C組,差異有統計學意義(P<0.05)。A、B組患兒總有效率比較差異無統計學意義(P躍0.05);C組患兒總有效率高于A組,差異有統計學意義(P<0.05);D組患兒總有效率高于A、B組,差異有統計學意義(P<0.05)。結論1%聚桂醇術前2週瘤體註射應用于嬰幼兒血管瘤,操作簡單方便,治療有效率較高,可有效促進瘤體消退,改善患兒的預後情況。
목적:비교1%취계순불동시간용약치료영유인혈관류적림상효과。방법안조수궤수자표법장80례혈관류환인분위A、B、C、D조,A조미경임하약물치료,B조채용1%취계순술전30 min류체주사,C조채용1%취계순술전48 h류체주사,D조채용1%취계순술전2주류체주사,비교4조환인VEGF평분、MVD평분급림상료효。결과 A조환인CD34양성반응정종갈색과립,강양성표체。 A、B조환인VEGF평분급MVD평분비교,차이무통계학의의(P약0.05);C조환인VEGF평분급MVD평분현저저우A、B조,차이유통계학의의(P<0.05);D조환인VEGF평분급MVD평분현저저우A、B、C조,차이유통계학의의(P<0.05)。A、B조환인총유효솔비교차이무통계학의의(P약0.05);C조환인총유효솔고우A조,차이유통계학의의(P<0.05);D조환인총유효솔고우A、B조,차이유통계학의의(P<0.05)。결론1%취계순술전2주류체주사응용우영유인혈관류,조작간단방편,치료유효솔교고,가유효촉진류체소퇴,개선환인적예후정황。
Objective To compare the clinical effects of 1% lauromacrogol medication on different time in the treat-ment of infantile hemangioma. Methods 80 cases of children with infantile hemangioma were randomly divided into group A,group B,group C,group D according to the random number table method.There was no drug treatment in group A,1% lauromacrogol lump body injection pre-operation 30-min was used in group B,1% lauromacrogol lump body in-jection pre-operation 48-h was applied in group C,1%lauromacrogol lump body injection pre-operation two weeks was used in group D.The score of VEGF and MVD,clinical effect in four groups was compared respectively. Results The CD34 positive reaction was strong positive expression,it showed brown granules in group A.There were no statistical difference on the score of VEGF and MVD between group A and group B (P>0.05).The score of VEGF and MVD in group C was significantly lower than that in group A and group B respectively,with statistical difference (P<0.05).The score of VEGF and MVD in group D was significantly lower than that in group A,group B,group C respectively,with statistical difference(P<0.05).There was no statistical difference on total effective rate between group A and group B(P>0.05).Total effective rate in group C was higher than that in group A,with statistical difference (P<0.05).Total effective rate in group D was higher than that in group A and group B respectively,with statistical difference (P<0.05). Conclu-sion 1% lauromacrogol lump body injection pre-operation two weeks applied in infantile hemangioma has easy opera-tion and high effective rate,can effectively promote tumor subsided,improve the prognosis of children.